Filter by

Search tool

Displaying 1 - 10 of 148
Document library

Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis

Epidemiological data are crucial to monitoring progress towards the 2030 Hepatitis C Virus (HCV) elimination targets. The aim was to estimate the prevalence of chronic HCV infection (cHCV) in the European Union...
EMCDDA webinar on updated ECDC-EMCDDA guidance
Media library

EMCDDA webinar: Updated ECDC–EMCDDA guidance on prevention and control of infectious diseases among people who inject drugs — practical implications

Recording of the EMCDDA webinar 'Updated ECDC–EMCDDA guidance on prevention and control of infectious diseases among people who inject drugs — practical implications'.
Document library

Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review

Background People who inject drugs are disproportionately affected by HIV and hepatitis C virus (HCV) infections, while there is little global data on HIV and HCV testing and treatment coverage of this...
pair of hands holding syringes with orange tops
News

Key interventions to prevent and control infections among people who inject drugs

Six interventions, one aim: to prevent and control infections among people who inject drugs. In new public health guidance released today , the European Centre for Disease Prevention and Control ( ECDC...
Cover of the report on Review of mathematical modelling studies of opioid agonist treatment and needle and syringe programmes for preventing hepatitis C transmission
Publications
Technical reports

Evidence for the effectiveness of interventions to prevent infections among people who inject drugs: Review of mathematical modelling studies of opioid agonist treatment and needle and syringe programmes for preventing hepatitis C transmission

This report describes the methods and findings of a systematic review of mathematical modelling studies of the population-level impact of opioid agonist treatment (OAT) and needle and syringe programmes (NSPs) on hepatitis...
Cover of the report on Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour
Publications
Technical reports

Evidence for the effectiveness of interventions to prevent infections among people who inject drugs: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour

This report describes the methods and findings of systematic reviews of the literature undertaken to update the European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and...
Computer simulation of a virus
Publications
Data factsheet

Viral hepatitis elimination barometer among people who inject drugs in Europe

The elimination barometer for hepatitis B and C among people who inject drugs is designed to support countries affiliated to the EMCDDA in monitoring their progress towards the Sustainable Development Goal 3.3...
Logo World Hepatitis Day
News

#WorldHepatitisDay: Helping to beat viral hepatitis

Every year, on 28 July, the World Health Organization (WHO) and partners commemorate World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes. Eliminating hepatitis as...
Logo: World Hepatitis Day. White font on dark blue circle with a lighter blue half line around the circle
Events

World Hepatitis Day 2023

World Hepatitis Day is observed each year on 28 July to raise awareness of viral hepatitis, an inflammation of the liver that causes severe liver disease and hepatocellular cancer. ‘We’re not waiting’...
International day
Data

Source data for Drug-related infectious diseases – the current situation in Europe (European Drug Report 2023)

This data bundle contains all source data used on the page, Drug-related infectious diseases – the current situation in Europe (European Drug Report 2023) .
Top